search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
74 NATURALS A C


B


D


Figure 2: Evaluation of the mitotic index through immunohistochemical staining of Ki-67. A : Untreated control epidermis. B: Treated epidermis with Serene Skin Sage (0.5%). C: Treated epidermis with Serene Skin Sage (1%) D:Treated epidermis with Serene Skin Sage (2.5%)


cellular proliferation in the skin tissue thanks to the skincare active. Ki-67 is the protein marker present during the active phases of the cell cycle, hence in the context of evaluating the mitotic index, tissue samples are treated with specific antibodies against Ki-67. This treatment allows for the visualization


and quantification of cells that are actively dividing. The mitotic index is determined by counting the number of Ki-67-positive cells in relation to the total number of cells observed. This information is valuable in assessing


the effects on cell growth and differentiation. In the case of the study the skincare active, the evaluation of the mitotic index using Ki-67 staining provided quantitative data on the stimulation of basal layer keratinocyte proliferation, demonstrating the effectiveness of the skincare active in promoting cell division and rejuvenation of the skin. By studying loricrin as a cell differentiation


marker, researchers gained valuable insights into the process of keratinocyte maturation and the development of the skin’s outermost layers. In the specific study on the skincare active, a notable increase of 21% in loricrin production was observed. Evaluating the synthesis of loricrin serves as a crucial measure to understand the impact of the skincare active


14 12 10 8 6 4 2 0


Control +22% +27% +32%


on the cornification process. At concentrations of 0.5%, 1% and 2.5%, the


skincare active produced an increase in loricrin of 21%, 27% and 32% respectively. By studying loricrin as a cell differentiation marker, researchers were able to assess the skincare active’s effect on the synthesis and distribution of this essential cornification protein, providing valuable insights into its ability to enhance the skin barrier function and promote a healthy turnover of skin cells. Studying the increase in the synthesis of free


fatty acids and ceramides, particularly in the stratum corneum and intercorneocyte cement, provides important insights into the effects of the skincare active. Free fatty acids and ceramides play crucial roles in maintaining the skin barrier function and hydration. Under the experimental conditions, the


skincare active exhibited significant lipolytic activity at concentrations of 0.5%, 1%, and 2.5%. This activity resulted in an increase in the hydrolysis of total lipids, specifically free fatty acids, of 20%, 25%, and 32% respectively. The increase in free fatty acids indicates the breakdown of triglyceride lipids, which contribute to a shiny complexion. Furthermore, the skincare active


demonstrated a significant effect on ceramide synthesis at concentrations of 0.5%, 1%,


6 5 4 3 2 1


0 0.5% 1% 2.5%


Figure 3: Loricrin rate based on concentration of the skincare active 0.5%, 1%, 2.5%


PERSONAL CARE October 2023 Control 0.5% 1% 2.5%


Figure 4: Free fatty acids rate based on concentration of the skincare active 0.5%, 1%, 2.5%


+20% +25% +32%


and 2.5%. The product stimulated ceramide synthesis by 22%, 28%, and 34% respectively compared to the untreated control. Ceramides are essential lipid molecules that help maintain skin barrier integrity and hydration levels. These findings highlight the efficacy of the


skincare active in promoting lipid balance and ceramide production, which are essential for maintaining a healthy skin barrier, preventing moisture loss, and contributing to a radiant complexion. The ability of the skincare active to enhance lipid synthesis and breakdown triglycerides further adds to its potential to improve skin texture and overall appearance.


Balancing and protective effects on the microbial environment The skincare active exhibits a key action of rebalancing the skin’s microbial environment (micro-organisms) and the expression of antimicrobial peptides. To evaluate the impact of the skincare


active, researchers looked at the adhesion of four bacterial strains, namely Staphylococcus epidermidis (a beneficial bacterium), Staphylococcus aureus, Corynebacterium xerosis, and Cutibacterium acnes (associated with various skin conditions). The adhesion of these bacteria was assessed on reconstructed


18 16 14 12 10 8 6 4 2 0


Control +34% +22% +28%


0.5%


1%


2.5%


Figure 5: Ceramides rate based on concentration of the skincare active 0.5%, 1%, 2.5%


www.personalcaremagazine.com


Loricrin rate (ng/ml)


Free Fatty Acids rate (nmol)


Ceramides (ng/ml)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108